News

2018 Mid-Year Update from WGND

As the global TB drug development community pushes forward to find new drug candidates and develop novel regimens to combat the TB epidemic, we'd like to highlight some updates in the field, WGND activities, and upcoming events in 2018. 

Upcoming Events in 2018: 

  • UN General Assembly holding high-level meeting on TB to take place 26 September 2018
  • 2018 WGND Annual Meeting is being planned to occur the week of October 23rd in The Hague, Netherlands. Further details will be disseminated soon.
More News
11 Aug 2020
The European Commission (EC) has provided conditional marketing authorization for pretomanid, a novel compound developed by TB Alliance, when used in combination with bedaquiline and linezolid as part of a six month, all-oral regimen for the treatment of adults with XDR-TB or treatment-intolerant...
29 Jul 2020
The WGND is announcing a call for applications to become a part of the WGND Core Group (CG). The CG provides leadership and sets the strategic direction for the work of the WGND. Addmitted applicants will begin their term in September 2020. Current CG membership information is available on the WGND...
9 Jul 2020
Earlier this week, Johnson & Johnson announced a reduction in the price for bedaquiline in low- and middle-income countries, as part of a collaboration with the Stop TB Partnership's Global Drug Facility (GDF). The immediate change in price will make bedaquiline available through the GDF at the...